Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 9:33 PM ET


Company Overview of Onyx Therapeutics, Inc.

Company Overview

Onyx Therapeutics, Inc. discovers, develops, and commercializes novel therapeutics that target protein degradation pathways for cancer and autoimmune diseases. The company develops a pipeline of novel proteasome inhibitors, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor. Its products include Carfilzomib (PR-171), a structural and mechanistical novel proteasome inhibitor that exhibits a level of selectivity for the unique N-terminal threonine active sites in the proteasome; PR-047, an oral proteasome inhibitor that demonstrates significant preclinical anti-tumor activity and a therapeutic window in animal models; and alternative targets. The company was form...

333 Allerton Avenue

South San Francisco, CA 94080

United States

Founded in 2002





Key Executives for Onyx Therapeutics, Inc.

Vice President of Regulatory Affairs and Quality Assurance
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Ausio Pharmaceuticals, LLC United States
Zuellig Group N.A., Inc. United States
PhaseBio Pharmaceuticals, Inc. United States
Serum Technologies Holdings, Inc. United States
Vemas Herb & Health United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Onyx Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at